Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Toledo
Clinical trial register · Spain

Clinical Trials in Toledo, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University of Castilla-La Mancha6 Merck Sharp & Dohme LLC3 Loxo Oncology, Inc.2 Blueprint Medicines Corporation2 Umbria Bioengineering Technologies2
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Toledo

52 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
Spanish Breast Cancer Research Group
Observational
300
San Sebastián, Barcelona, Madrid, Málaga, Seville, Toledo, Valencia
2026-09-30
Not yet open
University of Castilla-La Mancha
Not applicable
44
Toledo
2026-09
Recruiting
Spanish Prospective Registry of Hydra THV for Transcatheter Aortic Valve Implantation
NCT07566624Severe Aortic Valve Stenosis, Valvular Heart Disease, Aortic Valve Stenosis
Fundación EPIC
Observational
100
Fuencarral-El Pardo, Santiago de Compostela, Toledo
2026-07-07
By invitation
Cristina Lirio
Not applicable
54
Toledo
2026-06
Active, closed
Sinfatin S.L
Phase 1/2
8
Toledo
2026-05-13
Recruiting
Regeneron Pharmaceuticals
Phase 2
99
Barcelona, Marbella, Madrid, Salamanca, Toledo
2026-05-06
Recruiting
Inhibikase Therapeutics
Phase 3
486
Málaga, Barcelona, Santander, Madrid, Marbella, Seville, Toledo, Valencia
2026-04-23
Active, closed
Metformin Withdrawal In Metabolic Syndrome
NCT07659444Metabolic Syndrome (MetS), Glucose Intolerance
University of Castilla-La Mancha
Not applicable
21
Toledo
2026-04-05
Not yet open
Bipolar Radiofrequency for Genitourinary Syndrome of Menopause
NCT07419035Genitourinary Syndrome of Menopause (GSM)
University of Castilla-La Mancha
Not applicable
40
Toledo
2026-03-15
Recruiting
ABLE Human Motion S.L.
Not applicable
80
Toledo, Barcelona
2026-01-15
Recruiting
Insmed Incorporated
Phase 3
344
Palma de Mallorca, L'Hospitalet de Llobregat, Majadahonda, Barcelona, Madrid, Santiago de Compostela, Seville, Toledo
2026-01-07
Not yet open
Mechanical Insufflation-exsufflation and Hypertonic Saline in Nosocomial Bacterial Respiratory Tract Infection
NCT06310941Nosocomial Infection, Nosocomial Pneumonia, Tracheobronchitis, Mechanical Ventilation Complication
Hospital San Carlos, Madrid
Not applicable
100
Barcelona, Santa Cruz de Tenerife, Madrid, Vigo, Toledo
2026-01-01
Recruiting
Eli Lilly and Company
Phase 3
1,630
Barcelona, Castellon, Granada, Madrid, Málaga, San Sebastián de los Reyes, Santiago de Compostela, Toledo
2025-10-22
Recruiting
Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe)
Not applicable
1,200
Elche, Barcelona, Santander, Madrid, Oviedo, Toledo, Valencia
2025-10-08
Recruiting
AllRock Bio, Inc.
Phase 2
40
Madrid, Toledo
2025-10-01
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 2
30
Barcelona, Madrid, Seville, Toledo
2025-09-19
Recruiting
AbbVie
Observational
700
Málaga, León, Cartagena, El Palmar, Murcia, Pontevedra, Toledo
2025-09-09
Not yet open
RedCord in Neurogenic Bowel Dysfunction in Multiple Sclerosis
NCT06838624Multiple Sclerosis, Pelvic Floor Disorder
University of Castilla-La Mancha
Not applicable
76
Toledo
2025-09-01
Recruiting
Universidad Complutense de Madrid
Not applicable
34
Madrid, Toledo
2025-07-11
Recruiting
University of Castilla-La Mancha
Not applicable
78
Toledo
2025-05-26
Active, closed
VITUS Post-Market Registry
NCT06832631Peripheral Arterial Disease, Peripheral Arterial Occlusive Disease
OrbusNeich
Observational
283
Gijón, Granollers, Ourense, Toledo
2025-05-22
Active, closed
Merck Sharp & Dohme LLC
Phase 2
130
Palma, Santander, Barcelona, Madrid, Seville, Toledo
2025-05-12
Active, closed
Merck Sharp & Dohme LLC
Phase 2
440
Marbella, Barcelona, Madrid, Seville, Toledo
2025-04-16
Recruiting
Instituto de Investigación Marqués de Valdecilla
Observational
330
Santander, Alicante, Barcelona, Bilbao, Burgos, Madrid, Oviedo, Toledo
2025-03-01
Not yet open
Sierra Varona SL
Not applicable
48
Toledo
2025-02-24
Recruiting
MarsiBionics
Not applicable
20
Toledo
2025-02-17
Active, closed
Fundación para el Progreso de la Oncología en Cantabria
Phase 2
70
L'Hospitalet de Llobregat, Santander, Madrid, Pamplona, Toledo, Valladolid
2025-01-20
Active, closed
A Study of Mosliciguat in PH-ILD
NCT06635850Pulmonary Hypertension, Interstitial Lung Disease, Lung Diseases, Vascular Diseases
DrugMosliciguat
Pulmovant, Inc.
Phase 2
135
Santander, Marbella, Madrid, Toledo
2024-10-29
Recruiting
Novartis Pharmaceuticals
Phase 1/2
232
Santiago Compostela, Marbella, Toledo, Barcelona, Las Palmas de Gran C, Seville
2024-10-24
Recruiting
Gossamer Bio USA, Inc.
Phase 3
330
Barcelona, Madrid, Santander, Seville, Toledo
2024-09-03
Recruiting
Umbria Bioengineering Technologies
Not applicable
10,000
Córdoba, Murcia, Toledo
2024-03-15
Not yet open
IRCCS Fondazione Stella Maris
Observational
500
Toledo
2023-10-10
Active, closed
Eagle Pharmaceuticals, Inc.
Phase 2
276
Barcelona, Madrid, Santiago de Compostela, Tarragona, Terrassa, Toledo, Valencia, Valladolid
2023-07-22
Recruiting
Spanish Oncology Genito-Urinary Group
Phase 2
90
Barcelona, A Coruña, Lugo, Madrid, Toledo, Valencia, Valladolid, Zaragoza
2023-03-07
Recruiting
Poitiers University Hospital
Not applicable
670
Barcelona, L'Hospitalet de Llobregat, Oviedo, Toledo
2023-02-02
Recruiting
Umbria Bioengineering Technologies
Not applicable
600
Toledo
2023-01-07
Active, closed
AstraZeneca
Phase 3
1,174
Barcelona, Bilbao (Vizcaya), Elche(Alicante), Madrid, Málaga, Palma de Mallorca, Toledo, Valencia
2022-11-28
Active, closed
Cogent Biosciences, Inc.
Phase 2
237
Barcelona, Madrid, Toledo
2022-06-27
Recruiting
Neck Evolution With Ovation in Spain
NCT05823519Abdominal Aortic Aneurysm
DGM Vascular
Observational
120
Palma de Mallorca, Girona, Barakaldo, Burgos, Salamanca, Toledo, Gijón, Barcelona
2022-06-01
Recruiting
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
NCT05304377Chronic Myeloid Leukemia, Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive, Cml
DrugELVN-001
Enliven Therapeutics
Phase 1
250
Barcelona, Las Palmas de Gran Canaria, Madrid, Toledo, Valencia
2022-05-22
Recruiting
Blueprint Medicines Corporation
Phase 2/3
534
Barcelona, Madrid, Toledo
2021-11-30
Recruiting
Pfizer
Phase 3
893
Santiago de Compostela, L'Hospitalet Del Llobregat, Terrassa, Santander, Pamplona, Toledo, Barcelona, Girona
2021-10-04
Active, closed
Loxo Oncology, Inc.
Phase 3
600
Barcelona, Madrid, Majadahonda, Marbella, Oviedo, Pozuelo de Alarcón, Seville, Toledo
2021-09-20
Active, closed
Merck Sharp & Dohme LLC
Phase 3
815
Palma de Mallorca, Santander, Barcelona, Majadahonda, Madrid, Toledo
2021-05-12
Active, closed
Loxo Oncology, Inc.
Phase 3
238
L'Hospitalet de Llobregat, Toledo, Santiago de Compostela, Pozuelo de Alarcón, Madrid, Albacete, Barcelona, Cáceres
2021-03-09
Recruiting
Eisai Inc.
Phase 1/2
182
Badalona, Barcelona, Madrid, Toledo, Valencia
2020-08-06
Active, closed
BeOne Medicines
Phase 3
955
Barcelona, Girona, L'Hospitalet de Llobregat, Madrid, Salamanca, Toledo
2020-01-16
Recruiting
Movement and Behaviours Measurement Study
NCT04173715Aging, Physical Function, Frailty Syndrome, Physical Disability
University of Castilla-La Mancha
Observational
90
Toledo
2019-10-14
Active, closed
Blueprint Medicines Corporation
Phase 2
251
Barcelona, Toledo
2019-04-16
Active, closed
Tesaro, Inc.
Phase 3
1,400
Ávila, Badalona, Barcelona, Girona, Jaén, Madrid, Santiago de Compostela, Toledo
2018-10-11
Active, closed
Medtronic
Observational
3,100
A Coruña, Barcelona, Santiago de Compostela, Toledo, Vitoria-Gasteiz
2015-07
Recruiting
Boston Scientific Corporation
Observational
4,800
Ciudad Real, Madrid, Pamplona, San Sebastián, Santander, Toledo, Valencia
2012-11-19
Rows per page Showing 1–52 of 52
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 October 2026. https://priyalifescience.com/clinical-trials-spain/city/toledo

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 52 of those studies with a site in Toledo.

How many clinical trials are recruiting in Toledo?

28 of the 52 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 6 have not yet opened recruitment, 17 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Toledo), 52 studies
PhaseStudiesRecruitingShare
Not applicable15828.8%
Phase 211421.2%
Phase 311521.2%
Observational10719.2%
Phase 1/2325.8%
Phase 1111.9%
Phase 2/3111.9%

Most active sponsors

Lead sponsors with the most studies (Toledo)
Lead sponsorStudiesRecruiting
University of Castilla-La Mancha62
Merck Sharp & Dohme LLC30
Blueprint Medicines Corporation21
Loxo Oncology, Inc.20
Umbria Bioengineering Technologies22
AbbVie11
ABLE Human Motion S.L.11
Alexion Pharmaceuticals, Inc.11
AllRock Bio, Inc.11
AstraZeneca10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.